Myasthenia gravis is an autoimmune disorder that disrupts nerve-to-muscle communication. Learn the latest treatments-from pyridostigmine and thymectomy to FDA-approved biologics like FcRn inhibitors-that are transforming outcomes for patients in 2025.
read more